Viewing StudyNCT00047255



Ignite Creation Date: 2024-05-05 @ 11:27 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00047255
Status: COMPLETED
Last Update Posted: 2020-08-03
First Post: 2002-10-03

Brief Title: Docetaxel and Trastuzumab With or Without Carboplatin in Treating Women With HER2-Positive Breast Cancer
Sponsor: Jonsson Comprehensive Cancer Center
Organization: Jonsson Comprehensive Cancer Center

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
recurrent breast cancer View
stage IIIB breast cancer View
stage IIIC breast cancer View
stage IV breast cancer View